Case 39-2006: A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness

New England Journal of Medicine

Volumn 355, Issue 25, 2006, Pages 2678-2689

  Cha, Jang Ho J ^a,b   Furie, Karen ^a,b   Kay, Jonathan ^a,b   Walensky, Rochelle P ^a,b   Mullins, Mark E ^a,b   Hedley Whyte, E Tessa ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ATOVAQUONE; AZATHIOPRINE; CASPOFUNGIN; CLINDAMYCIN; CORTICOSTEROID; DAPSONE; DEXAMETHASONE; ETANERCEPT; ETIRACETAM; FENTANYL; FLUCONAZOLE; FLUOXETINE; FOLINIC ACID; LEFLUNOMIDE; LORAZEPAM; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; NICOTINE; PANTOPRAZOLE; PHENYTOIN; PREDNISONE; PYRIMETHAMINE; SULFANILAMIDE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ADULT; ARM WEAKNESS; ARTICLE; BRAIN BIOPSY; BRAIN DAMAGE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PARIETAL LOBE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEIZURE; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; ACANTHAMOEBA; AMEBIASIS; ANIMAL; ARM; BLOOD ANALYSIS; BRAIN; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ENCEPHALITIS; FATALITY; GRANULOMA; ISOLATION AND PURIFICATION; MUSCLE WEAKNESS; PARASITOLOGY; PATHOLOGY;

ACANTHAMOEBA; ADULT; AMEBIASIS; ANIMALS; ARM; BLOOD CHEMICAL ANALYSIS; BRAIN; ENCEPHALITIS; FATAL OUTCOME; FEMALE; GRANULOMA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MUSCLE WEAKNESS; SEIZURES;

EID: 33845714108     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc069030     Document Type: Article

References (35)

1. Lee BY, Newberg AB, Liebeskind DS, Kung J, Alavi A. FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med 2004;29:620-5.
2. Stahl NI, Klippel JH, Decker JL. Fever in systemic lupus erythematosus. Am J Med 1979;67:935-40.
3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
4. Senecal JL, Raymond Y. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? J Rheumatol 2004;31:2093-8.
5. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
6. Hanly JG, Liang MH. Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann N Y Acad Sci 1997;823:60-8.
7. Hanly JG, Cassell K, Fisk JD. Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 1997;40:1542-3.
8. Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002;41:1308-12.
9. Petri M. Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 1994;6:481-6.
10. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985;55:87-98.
11. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002;41:619-30.
12. Jennekens FG, Kater L. Idem. The central nervous system in systemic lupus erythematosus. 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002;41:605-18.
13. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003;61:108-10.
14. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-500.
15. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24:423-56.
16. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987;66:341-8.
17. Hung JJ, Ou LS, Lee WI, Huang JL. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005;32:40-3.
18. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996;25:318-36.
19. Ehlers S. Why does tumor necrosis factor targeted therapy reactivate tuberculosis? J Rheumatol Suppl 2005;74:35-9.
20. Wilcox MH, Powell RJ, Pugh SF, Balfour AH. Toxoplasmosis and systemic lupus erythematosus. Ann Rheum Dis 1990;49:254-7.
21. Dubin HV, Courter MH, Harrell ER. Toxoplasmosis: a complication of corticosteroid- and cyclophosphamide-treated lupus erythematosus. Arch Dermatol 1971;104:547-50.
22. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-64.
23. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62:1934-8.
24. Case Records of the Massachusetts General Hospital (Case 8-1993). N Engl J Med 1993;328:566-73.
25. Case Records of the Massachusetts General Hospital (Case 8-2006). N Engl J Med 2006;354:1178-84.
26. Shirwadkar CG, Samant R, Sankhe M, et al. Acanthamoeba encephalitis in patient with systemic lupus, India. Emerg Infect Dis 2006;12:984-6.
27. Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol 2005;43:1689-93.
28. Bloch KC, Schuster FL. Inability to make premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis. J Clin Microbiol 2005;43:3003-6.
29. Grunnet ML, Carron GH, Kushner LS. Fulminant amebic meningoencephalitis due to Acanthamoeba. Neurology 1981;31:174-6.
30. Koide J, Okusawa E, Ito T, et al. Granulomatous amoebic encephalitis caused by Acanthamoeba in a patient with systemic lupus erythematosus. Clin Rheumatol 1998;17:329-32.
31. Uschuplich V, Mileusnic D, Johnson M. Pathologic quiz case: progressive fatal encephalopathy in an immunosuppressed patient with a history of discoid lupus erythematosus: subacute granulomatous meningoencephalitis (Acanthamoeba culbertsoni). Arch Pathol Lab Med 2004;128(9):e109-e111.
32. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003;16:273-307.
33. Pisani F, Costa C, Oteri G, Ioli A. Identification of amoebae in the CSF in a patient with meningoencephalitis. J Neurol Neurosurg Psychiatry 2003;74:1445-6.
34. Huang ZH, Ferrante A, Carter RF. Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis. J Infect Dis 1999;179:1305-8.
35. Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis 2003;37:1304-12.